Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Evaluation of adropin, fibroblast growth factor-1 (FGF-1), and Toll-like receptor-1 (TLR1) biomarkers in patients with inflammatory bowel disease: gene expression of TNF-α as a marker of disease severity, Egyptian Journal of Medical Human Genetics, June 2024, Springer Science + Business Media,
DOI: 10.1186/s43042-024-00533-2.
You can read the full text:

Read

Contributors

The following have contributed to this page